Spots Global Cancer Trial Database for chronic hepatitis b
Every month we try and update this database with for chronic hepatitis b cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection | NCT03253250 | Chronic Hepatit... Hepatic Carcino... | ETV；TDF；ADV Peginterferon A... | 18 Years - 70 Years | Huashan Hospital | |
| Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients | NCT04646928 | Chronic Hepatit... | 20 Years - 75 Years | CHA University | ||
| The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) | NCT00397540 | Carcinoma, Hepa... Chronic Hepatit... | PEIT RFTA | 19 Years - 80 Years | Seoul National University Hospital | |
| Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection | NCT04294498 | Advanced Hepato... | Durvalumab | 20 Years - | National Taiwan University Hospital | |
| The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection | NCT03253250 | Chronic Hepatit... Hepatic Carcino... | ETV；TDF；ADV Peginterferon A... | 18 Years - 70 Years | Huashan Hospital | |
| Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers | NCT02991638 | Chronic Lymphoc... Indolent B-cell... Chronic Hepatit... Lymphoma, Small... Mantle-Cell Lym... Waldenstrom's M... Follicular Lymp... | Ibrutinib | 18 Years - | The University of Hong Kong | |
| Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial | NCT02817685 | Chronic Hepatit... | 3 months 6 months 3 month ultraso... | 18 Years - 80 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers | NCT02991638 | Chronic Lymphoc... Indolent B-cell... Chronic Hepatit... Lymphoma, Small... Mantle-Cell Lym... Waldenstrom's M... Follicular Lymp... | Ibrutinib | 18 Years - | The University of Hong Kong | |
| Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy | NCT01270178 | Chronic Hepatit... Hepatocellular ... | Entecavir | 20 Years - | Taipei Veterans General Hospital, Taiwan | |
| Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis | NCT04160897 | Hepatitis B, Ch... Hepatocellular ... Compensated Cir... | Entecavir Tenofovir Disop... | 18 Years - 80 Years | Ruijin Hospital | |
| Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography | NCT01360892 | Chronic Hepatit... Chronic Hepatit... | 20 Years - | Kindai University | ||
| A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients | NCT05671315 | Chronic Hepatit... Intermediate to... | Peginterferon a... Nucleos(t)ide a... | 18 Years - 60 Years | Ruijin Hospital | |
| Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy | NCT02056548 | Lymphoma Chronic Hepatit... | 18 Years - | Seoul St. Mary's Hospital | ||
| The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study | NCT01831037 | Chronic Hepatit... Chronic Hepatit... | Regression of f... Specific risk f... | 18 Years - 70 Years | University of Arkansas | |
| Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy | NCT02081469 | Hepatitis B, Ch... Tumor | TDF | 18 Years - 70 Years | Chang Gung Memorial Hospital | |
| Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer | NCT05721300 | Hepatocellular ... Chronic Hepatit... | NAs（"Entecavir"... NAs （"Entecavir... | 35 Years - 75 Years | Zhongshan Hospital (Xiamen), Fudan University | |
| Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma | NCT01872988 | Chronic Hepatit... Hepatocellular ... | Tenofovir Placebo | 20 Years - | Taichung Veterans General Hospital | |
| Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography | NCT01360892 | Chronic Hepatit... Chronic Hepatit... | 20 Years - | Kindai University | ||
| Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma | NCT02779465 | Hepatitis B Carcinoma, Hepa... | Vitamin D3 | 18 Years - 70 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) | NCT00397540 | Carcinoma, Hepa... Chronic Hepatit... | PEIT RFTA | 19 Years - 80 Years | Seoul National University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
